CVS Stock Outlook: Fresh Legal Headlines, Analyst Upgrades and 2026 Forecast (December 6, 2025)
CVS Health Corp (NYSE: CVS) is back in the spotlight. As of December 6, 2025, CVS stock is trading around $75.60 per share, following a powerful 2025 rally but also a wave of fresh legal settlements, a major goodwill write‑down and renewed questions about its clinic strategy. At the same time, management has raised 2025 profit guidance, is signaling double‑digit earnings growth in 2026, and Wall Street now sees mid‑teens to low‑20% upside over the next 12 months. StockAnalysis+3Q4 Holdings+3Fierce Healthcare+3 Below is a detailed, news‑driven look at CVS: the latest developments as of December 6, 2025, plus forecasts, risks